When Connecticut was facing a projected budget gap of $3.8 billion, the governor's office and a coalition of unions considered how to make changes to the state health plan in order to mitigate the shortfall.
This article was collaboratively written by A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design (V-BID), and several V-BID Center staff.
In fiscal year 2012, the State of Connecticut faced a projected budget gap of $3.8 billion. The governor’s office and a coalition of unions representing state employees considered a wide range of options to mitigate this shortfall, including changes to the state health plan covering active and retired state employees. The parties focused healthcare discussions on methods to improve health as a means to control long-term costs. This led to the October 2011 launch of an uncommonly innovative initiative—the Connecticut Health Enhancement Program (HEP).
HEP is designed to incorporate the principles of value-based insurance design (VBID). This entails: 1) reducing financial barriers that deter use of evidence-based services and high-performing providers; and 2) imposing disincentives that discourage use of low-value care. By eliminating barriers to specified clinical services based on beneficiary demographics and medical history, payers, purchasers, taxpayers, and consumers can attain more health for every dollar spent.
To learn more about the Connecticut Health Enhancement Plan, view the infographic below, and read the issue brief and 2015 update on the V-BID Center website.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen